Francisco Ward, DO
Interventional Pain Medicine · Columbia, MDNPI 1245225226
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $3,172 of the $3,631 with a category attached, or 87.4%. It is spread thinly across 32 manufacturers, the largest accounting for just 16.9% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $1,024 and has fallen 97.9% since, to $21 in 2025. That places this record below the midpoint for interventional pain medicine clinicians in MD, where the typical reported total is $3,506.
Across 100 payments — averaging $36.31 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Stimwave Technologies Incorporated$614
- AbbVie$309
- Foundation Fusion Solutions, LLC$294
- GRT US Holding, Inc.$290
- Boston Scientific$267
- Abbott$217
- plus $2K from 26 others
What the payments were for
- Travel & lodging$39911%
- Food & beverage$3,17287%
- Entertainment$602%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Stimwave Technologies Incorporated | 5 | $614 |
| AbbVie | 19 | $309 |
| Foundation Fusion Solutions, LLC | 6 | $294 |
| GRT US Holding, Inc. | 7 | $290 |
| Boston Scientific | 5 | $267 |
| Abbott | 4 | $217 |
| Medtronic | 5 | $214 |
| Spinal Simplicity, LLC | 1 | $197 |
| Biotronik NRO, Inc. | 3 | $196 |
| Protega Pharmaceutials Inc | 8 | $147 |
| Amgen | 1 | $124 |
| Collegium Pharmaceutical, Inc. | 8 | $124 |
| Angiodynamics, Inc. | 1 | $77 |
| Johnson & Johnson | 2 | $64 |
| Nevro Corp. | 3 | $58 |
| Vertex | 2 | $49 |
| Electronic Waveform Lab, Inc. | 2 | $49 |
| Novartis | 2 | $42 |
| Almatica Pharma LLC | 2 | $42 |
| Biohaven Pharmaceutical Holding Company Ltd. | 2 | $36 |
| Vertos Medical, Inc. | 1 | $30 |
| Painteq LLC | 1 | $24 |
| Saluda Medical Americas, Inc. | 1 | $24 |
| Averitas Pharma Inc. | 1 | $21 |
| Pfizer | 1 | $19 |
| Scilex Pharmaceuticals Inc. | 1 | $17 |
| Pacira Therapeutics, Inc. | 1 | $16 |
| Flowonix Medical Incorporated | 1 | $15 |
| Ultragenyx Pharmaceutical Inc. | 1 | $14 |
| Fidia Pharma USA Inc. | 1 | $13 |
| Metacel Pharmaceuticals LLC | 1 | $13 |
| Biodelivery Sciences International, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- StimQ Receiver Stimulator Kit Channel A US w Receiver$607
- StimQ Freedom 4A Receiver Kit Channel A US Receiver$607
- StimQ Freedom 8A Receiver Kit Channel A US w Receiver$607
- Freedom 4A Receiver Kit Channel A US w Receiver$607
- Freedom 8A Receiver Kit Channel A US w Receiver$607
- Infinion 16$206
- HA MINUTEMAN G3-R$197
- INTELLIS ADAPTIVESTIM$141
- Prospera$129
- Qutenza$125
- AIMOVIG$124
- PROCLAIM$118
How this compares
$3,631 in reported general payments places this provider in the 50th percentile of 56 interventional pain medicine providers in Maryland.
See all interventional pain medicine providers in Maryland →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| BelbucaBuprenorphine Hcl | 17 | $5,576 |
| OxycontinOxycodone Hcl | 11 | $4,445 |
| MovantikNaloxegol Oxalate | 11 | $1,953 |
| Diclofenac Sodium | 40 | $1,785 |
| Oxycodone Hcl | 99 | $1,754 |
| Pregabalin | 41 | $1,202 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 70 | $1,168 |
| Tramadol Hcl ErTramadol Hcl | 11 | $1,059 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 40 | $1,001 |
| Tramadol Hcl | 105 | $732 |
| Morphine Sulfate ErMorphine Sulfate | 28 | $636 |
| Fentanyl | 11 | $546 |
| Duloxetine Hcl | 20 | $509 |
| Celecoxib | 32 | $428 |
| Gabapentin | 58 | $420 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Collegium Pharmaceutical, Inc.Belbuca | $124 | $5,57617 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 50th percentile of 56 interventional pain medicine providers in Maryland.
Other interventional pain medicine in Columbia
- Abdul SoudanColumbia$10K
- Romana BaigColumbia$42
- Mark ColemanPikesville$1.3M
- Marc LoevRockville$318K
- Anish PatelFrederick$311K
- Aneesh SinglaSalisbury$167K
- Charles SimmonsAnnapolis$62K
- Ali El-MohandesHagerstown$57K
- Michael WongBel Air$31K
- Anna IrwinBethesda$30K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.